In vitro placental model optimization for nanoparticle transport studies

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 497-510

  Cartwright, Laura ^a   Poulsen, Marie Sønnegaard ^b   Nielsen, Hanne Mørck ^c   Pojana, Giulio ^d   Knudsen, Lisbeth E ^b   Saunders, Margaret ^a   Rytting, Erik ^b,e  

^a FOREST RESEARCH   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d CA' FOSCARI UNIVERSITY OF VENICE   (Italy)

^e University of Texas Medical Branch School of Medicine   (United States)

Author keywords

BeWo cells; Model optimization; Nanoparticles; Nanotoxicology; Placenta; Transport

Indexed keywords

FLUORESCEIN; NANOPARTICLE; POLYCARBONATE; POLYSTYRENE; SODIUM;

ARTICLE; CELL GROWTH; CELL MEMBRANE PERMEABILITY; CELL TRANSPORT; CHORIOCARCINOMA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRIC RESISTANCE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; PARTICLE SIZE; PERMEABILITY BARRIER; PLACENTAL TRANSFER; POROSITY; PROCESS MODEL; SODIUM TRANSPORT; TIGHT JUNCTION; TRANSCYTOSIS; TRANSMISSION ELECTRON MICROSCOPY; TRANSPORT KINETICS; TROPHOBLAST;

CELL LINE, TUMOR; CELL SURVIVAL; CHORIOCARCINOMA; FEMALE; FLUORESCENT DYES; HUMANS; MEMBRANE PROTEINS; NANOPARTICLES; PARTICLE SIZE; PERMEABILITY; PHOSPHOPROTEINS; PLACENTA; POLYCARBOXYLATE CEMENT; POLYESTERS; POROSITY; PREGNANCY; REPRODUCIBILITY OF RESULTS; TRANSCYTOSIS; UTERINE NEOPLASMS;

EID: 84856658620     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Moghimi SM, Kissel T. Particulate nanomedicines. Adv Drug Deliv Rev. 2006;58(14):1451-1455.
2. Dusinska M, Fjellsbo L, Magdolenova Z, et al. Testing strategies for the safety of nanoparticles used in medical applications. Nanomedicine (Lond). 2009;4(6):605-607.
3. Saunders M. Transplacental transport of nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1(6):671-684.
4. Myllynen PK, Loughran MJ, Howard C V, et al. Kinetics of gold nano-particles in the human placenta. Reprod Toxicol. 2008;26(2):130-137.
5. Wick P, Malek A, Manser P, et al. Barrier capacity of human placenta for nanosized materials. Environ Health Perspect. 2010;118(3):432-436.
6. Sastry B V. Techniques to study human placental transport. Adv Drug Deliv Rev. 1999;38(1):17-39.
7. Moe AJ. Placental amino acid transport. Am J Physiol. 1995;268(6 Pt 1): C1321-C1331.
8. Bechi N, Ietta F, Romagnoli R, et al. Estrogen-like response to p-nonylphenol in human frst trimester placenta and BeWo choriocarci-noma cells. Toxicol Sci. 2006;93(1):75-81.
9. Mathiesen L, Mose T, Mørck TJ, et al. Quality assessment of a placental perfusion protocol. Reprod Toxicol. 2010;30(1):138-146.
10. Rytting E, Bryan J, Southard M, Audus KL. Low-affnity uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (4-Di-1-ASP) in BeWo cells. Biochem Pharmacol. 2007;73(6):891-900.
11. Poulsen MS, Rytting E, Mose T, Knudsen LE. Modeling placental transport: correlation of in vitro BeWo cell permeability and ex vivo human placental perfusion. Toxicol In Vitro. 2009;23(7):1380-1386.
12. Correia CS, Cartwright L, Mathiesen L, Knudsen LE, Saunders M. Studying placental transfer of highly purifed non-dioxin-like PCBs in two models of the placental barrier. Placenta. 2011;32(3):283-291.
13. Rytting E, Audus KL. Novel organic cation transporter 2-mediated car-nitine uptake in placental choriocarcinoma (BeWo) cells. J Pharmacol Exp Ther. 2005;312(1):192-198.
14. Rytting E, Audus KL. Effects of low oxygen levels on the expression and function of transporter OCTN2 in BeWo cells. J Pharm Pharmacol. 2007;59(8):1095-1102.
15. Bode CJ, Jin H, Rytting E, Silverstein PS, Young AM, Audus KL. In vitro models for studying trophoblast transcellular transport. Methods Mol Med. 2006;122:225-239.
16. Henning A, Schneider M, Nafee N, et al. Infuence of particle size and material properties on mucociliary clearance from the airways. J Aerosol Med Pulm Drug Deliv. 2010;23(4):233-241.
17. Sarlo K, Blackburn KL, Clark ED, et al. Tissue distribution of 20 nm, 100 nm and 1000 nm fuorescent polystyrene latex nanospheres following acute systemic or acute and repeat airway exposure in the rat. Toxicolog y. 2009;263(2-3):117-126.
18. Geys J, Coenegrachts L, Vercammen J, et al. In vitro study of the pulmonary translocation of nanoparticles: a preliminary study. Toxicol Lett. 2006;160(3):218-226.
19. Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H. Skin penetration and distribution of polymeric nanoparticles. J Control Release. 2004;99(1):53-62.
20. Johnston HJ, Semmler-Behnke M, Brown DM, Kreyling W, Tran L, Stone V. Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and hepatocyte cell lines in vitro. Toxicol Appl Pharmacol. 2010;242(1):66-78.
21. Dausend J, Musyanovych A, Dass M, et al. Uptake mechanism of oppositely charged fuorescent nanoparticles in HeLa cells. Macromol Biosci. 2008;8(12):1135-1143.
22. Amrite AC, Kompella UB. Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration. J Pharm Pharmacol. 2005;57(12):1555-1563.
23. Tian F, Razansky D, Estrada GG, et al. Surface modifcation and size dependence in particle translocation during early embryonic development. Inhal. Toxicol. 2009;21(Suppl 1):92-96.
24. Liu F, Soares MJ, Audus KL. Permeability properties of monolayers of the human trophoblast cell line BeWo. Am J Physiol. 1997;273(5 Pt 1): C1596-C1604.
25. Nanovskaya T, Nekhayeva I, Karunaratne N, Audus K, Hankins GD, Ahmed MS. Role of P-glycoprotein in transplacental transfer of methadone. Biochem Pharmacol. 2005;69(12):1869-1878.
26. Bhabra G, Sood A, Fisher B, et al. Nanoparticles can cause DNA damage across a cellular barrier. Nat Nanotechnol. 2009;4(12):876-883.
27. Lahtinen U, Honsho M, Parton RG, Simons K, Verkade P. Involvement of caveolin-2 in caveolar biogenesis in MDCK cells. FEBS Lett. 2003; 538(1-3):85-88.
28. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. Size-dependent proinfammatory effects of ultrafne polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafnes. Toxicol Appl Pharmacol. 2001;175(3):191-199.
29. Heaton SJ, Eady JJ, Parker ML, et al. The use of BeWo cells as an in vitro model for placental iron transport. Am J Physiol Cell Physiol. 2008;295(5): C1445-C1453.